Tempus

About

Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare.

Chicago,Illinois,United States
1001 - 5000
https://www.tempus.com

Highlights

Details

Last Funding Type: Series Unknown
Last Funding Money Raised: $100M
Industries: Artificial Intelligence,Biotechnology,Health Care,Machine Learning,Medical
Founded date: Jan 1, 2015
Number Of Employee: 1001 - 5000
Operating Status: Active
Legal Name: Tempus Labs, Inc.
Also Known As: Tempus Labs

Tempus is a technology company advancing precision medicine through the practical application of artificial intelligence in healthcare. With one of the world’s largest libraries of clinical and molecular data, and an operating system to make that data accessible and useful.

Tempus enables physicians to make real-time, data-driven decisions to deliver personalized patient care and in parallel facilitates the discovery, development, and delivery of optimal therapeutics. The goal is for each patient to benefit from the treatment of others who came before by providing physicians with tools that learn as the company gathers more data.

Tempus was established in 2015 by Eric Lefkofsky in Chicago, Illinois.

Funding Rounds

Number of Funding Rounds

Total Funding Amount

13

$1.34B

Tempus has raised a total of $1.34B in funding over 2 rounds. Their latest funding was raised on Oct 20, 2022 from a Series Unknown round.

Announced Date	Round	Money Raised	Number of Investors	Lead Investors	Post Valuation
Oct 20, 2022	Series Unknown	$100M	—	—	—	Detail
Oct 20, 2022	Debt Financing	$175M	1	—	—	Detail
Dec 10, 2020	Series G	$200M	6	Google	—	Detail
Dec 10, 2020	Debt Financing	$250M	—	—	—	Detail
Mar 13, 2020	Series G	$100M	5	—	—	Detail

Investments

Number of Investments

Number of Lead Investments

3

1

Tempus has made 3 investments. Their most recent investment was on Apr 9, 2018, when 8Trip raised ¥600M.

Date Company Name	Round	Money Raised	Industry	Lead Investor
Apr 9, 2018 8Trip	Series C	¥600M	Adventure Travel	Yes
Sep 27, 2017 Exicure	Series Unknown	$20M	Biotechnology	—
Oct 21, 2015 Exicure	Series Unknown	$14.79M	Biotechnology	—

Investors

Number of Lead Investors

Number of Investors

6

11

Tempus is funded by 11 investors. Google and Ares Management are the most recent investors.

Investor Name	Lead Investor	Funding Round
Google	Yes	Series G
Ares Management	—	Debt Financing
Baillie Gifford	—	Series G
Eric Lefkofsky	—	Series G
Franklin Templeton Investments	—	Series G
Novo Holdings	—	Series G
T. Rowe Price	—	Series G
Franklin Templeton	—	Series G
New Enterprise Associates	—	Series G
Revolution	—	Series F